Next-Generation ALK Inhibitors in Non-Small Cell Lung Cancer

0 Views
administrator
administrator
07/14/23

Experts discuss the next-generation ALK inhibitors ceritinib and AP26113 as treatments for patients with non-small cell lung cancer.

For more from this discussion, visit http://www.onclive.com/peer-exchange/nsclc-needs

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next